Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05447325 · ClinicalTrials.gov registry record · NA
Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Use Escalation Among Young Adult Electronic Nicotine Delivery Systems Users
A NA study of Message Exposure (Sequence: Regular Then Flavor) and Message Exposure (Sequence: Flavor Then Regular), sponsored by University of Georgia.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05447325 is a NA study of Message Exposure (Sequence: Regular Then Flavor) and Message Exposure (Sequence: Flavor Then Regular) that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05447325, a NA study of Message Exposure (Sequence: Regular Then Flavor) and Message Exposure (Sequence: Flavor Then Regular), is actively recruiting participants, sponsored by University of Georgia.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
180 young adult vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, prospectively linked to a 1-year randomized controlled trial. Baseline fMRI tasks will probe critical neurocognitive markers with high potential to account for individual differences in nicotine use prognosis and responsiveness to anti-vaping public service announcements (PSAs). Participants will be assigned randomly to a survey-only control condition, or one of two intervention orders, Regular PSA then Flavor PSA, and Flavor PSA then Regular PSA (n=60 each) in a 1-year counterbalanced crossover design. Every week intervention groups will receive anti-vaping PSAs either do not specifically address harms associated with vaping flavors (regular PSAs) or PSAs with a theme focusing on the harms of flavored vape products (flavor PSAs). Participants of the intervention groups will switch PSA exposure condition after 6 months. Their evaluations of the PSAs will be assessed with brief weekly online surveys. The links to the weekly online surveys will be sent via e-mail and text which allow them to access the surveys using any device with an internet browser. During the survey, the PSA of that week will first be displayed to PSA groups (n=120), followed by a query to provide message evaluation. Afterward, the survey questions will also assess their e-cigarette, cigarette, other tobacco use, and nicotine dependence, during the past week. The control group (n=60) will complete the surveys without viewing PSAs. In-person assessments at 3, 6, 9, and 12 months will biochemically confirm nicotine exposure.
Conditions Studied
Interventions
- BEHAVIORAL Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes)
- BEHAVIORAL Exposure to Anti-Vaping Messages (flavor-specific themes then generic themes)
- BEHAVIORAL Exposure to Anti-Vaping Messages (no message exposure)
Study Locations (1)
Georgia
- UGA Bio-imaging Research Center - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2022-07-15 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05447325
The ClinicalTrials.gov registry entry for NCT05447325 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Message Exposure (Sequence: Regular Then Flavor) appearing as the primary indexed condition, and to 3 interventions - of which Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes) is the first listed.
NCT05447325 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05447325 about?
NCT05447325 is a clinical study titled "Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Use Escalation Among Young Adult Electronic Nicotine Delivery Systems Users". 180 young adult vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, prospectively linked to a 1-year randomized controlled trial. Baseline fMRI tasks will probe critical neurocognitive markers with high potential to account for i...
What is the current status of trial NCT05447325?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2022-07-15. Estimated completion is 2026-07-31.
What conditions does trial NCT05447325 study?
This clinical trial studies the following conditions: Message Exposure (Sequence: Regular Then Flavor), Message Exposure (Sequence: Flavor Then Regular), No Message Exposure (Control Condition).
What interventions are being tested in trial NCT05447325?
The interventions under investigation include: Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes) (BEHAVIORAL), Exposure to Anti-Vaping Messages (flavor-specific themes then generic themes) (BEHAVIORAL), Exposure to Anti-Vaping Messages (no message exposure) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05447325?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05447325 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Message Exposure (Sequence: Regular Then Flavor)
All registered trials for this condition
Message Exposure (Sequence: Flavor Then Regular)
All registered trials for this condition
Georgia
All trials with a study site in Georgia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.